Data da primeira publicação: 11.01.2022
The case had been brought against Hamilton Medical AG ("Hamilton") by Fleur Tehrani in November 2019, alleging that Hamilton’s INTELLiVENT-ASV (
The decision confirmed Hamilton’s argument. Although found to cover INTELLiVENT-ASV, the patent was invalid because it was not new - its subject matter had been clearly and unambiguously disclosed in a publication dating from 1995. This success for Hamilton brings to an end the dispute commenced by Fleur Tehrani in the UK.